Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Proteinuria Indicates Heart Disease Risk in Whites, But Not in Blacks

By LabMedica International staff writers
Posted on 29 Jan 2010
The cardiovascular risk of atherosclerosis associated with proteinuria--high levels of albumin in the urine--has race-dependent effects, according to a new study.

Researchers at Wake Forest University (WFU; Winston-Salem, NC, USA) evaluated whether excess protein excretion in the urine, a major heart disease risk factor in whites, was also a risk factor for heart and vascular disease in blacks. More...
To do so, the level of urine protein was examined in 835 white participants (mean age 61.7 years) and 393 black (mean age 56.7 years) participants, all with diabetes for approximately 10 years. Participants were also tested for atherosclerosis, based on the buildup of calcium in their major arteries.

The researchers found that in African American and European American participants, respectively, median calcified plaque mass scores were 53.5 and 291 for the coronary artery, 3 and 35.5 for the carotid artery, and 761 and 3,237 for the aorta. With adjustment for age, sex, glomerular filtration rate (GFR), and body mass index (BMI), proteinuria was significantly associated with calcified plaque in European Americans but not in African Americans, with significant ethnic interaction. Ethnic differences in this relationship persisted after adjustment for blood pressure, smoking, lipids, and use of acetylcholine-esterase (ACE) inhibitors or angiotensin receptor blockers. The study was published in the January 2010 issue of Diabetes Care.

"Excess protein in the urine, a common finding with progressive kidney disease in individuals with diabetes, is strongly associated with calcium deposition in the major arteries in white patients, but not in black patients,” said lead author Barry Freedman, M.D., chief of the section on nephrology at the WFU School of Medicine. "In the medical community, it is believed that the more protein in a patient's urine, the greater the risk for heart disease and stroke, and this is true - in white populations. There may be biologic factors predisposing whites to heart disease or protecting blacks from developing it.”

Related Links:
Wake Forest University





Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.